Combining health technology assessment and health technology management to deliver cost-effective prescribing and cost containment - the Irish experience.

Healthcare payers are increasingly recognizing the benefits of HTM particularly when used in conjunction with HTA. This review highlights several examples whereby significant cost-savings can be made through HTM of not only new drugs but also drugs which are already available on the market.